Wang, E <br/><br/>
In vivo activity and pharmacokinetics of ziracin (SCH27899), a new long-acting everninomicin antibiotic, in a murine model of penicillin-susceptible or penicillin-resistant pneumococcal pneumonia.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Apr 2000 
 - 1010-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.44.4.1010-1018.2000  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminoglycosides<br/>Animals<br/>Anti-Bacterial Agents--pharmacokinetics<br/>Ceftriaxone--pharmacokinetics<br/>Cephalosporins--pharmacokinetics<br/>Female<br/>Leukopenia--complications<br/>Lung--metabolism<br/>Mice<br/>Microbial Sensitivity Tests<br/>Penicillin Resistance<br/>Pneumonia, Pneumococcal--drug therapy<br/>Serum Bactericidal Test<br/>Streptococcus pneumoniae--drug effects<br/>Survival Analysis<br/>Vancomycin--pharmacokinetics